Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ !(MA5L-
/t$+Af,}
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© <;$Sa's,LE
vh1
Ma<cx
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© Pi
&fwGL
&.cGj@1!J
1.Co-stimulators (or co-stimulating molecules) mJ6t.%'
d
N3XVT{yo
2.NK-kB L337/8fh
2 Ft0C2
3.Immunoglobulin superfamily C&gOA8nf
/I`cS%U
4.antigen-presenting cell (APC) /?.r!Cp
5@R15q@c6n
5.death domain K]H"qG.K
SHXa{-
6.CCR and CXCR SxLHFN]
BRo
R"#'
7.Lectin (or mitogen) J[&
7,}
YobC'c\~9
8.Clusters of differentiation, CD) zCj*:n
GDo)6du
9.B7 family ?vht~5'
2#$}yP~
10.Cytotoxic T lymphocyte, CTL) ySr091Q
VuO)
11.IL-15 and IL-15 receptor (IL-15R) Sq?6R}q%
IxEQh)J X
12.MHC restriction W{$+mow7S
tvj'{W
13.Affinity-chromatography 6bRQL}[
@
@3)D%h
14.Cyctosprin A, CsA mTXNHvv
:nbW.B3GV
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) 0-t4+T
O'&X aaZV
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© qs8K jG@
COkLn)+0
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 1CS]~1Yp:
93Ci$#<y
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ .2(@jx,[
(W}i287
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ d'g{K]=tF
2fL88/'
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© QLpTz"H
M;RnH##W
ÃâÒßѧרҵ£º bbPd&7
um0}`Xq ^
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ Med"dHo7
}~\].I6
Ïû»¯ÄÚ¿Æ£º B,VSFpPx
4iPua"8
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ xz+`]Q
cwW~ *90#
ѪҺ²¡Ñ§×¨Òµ£º n5,Pq+[
hk$nlc|$
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿